601-609
Original Article
Open AccessClinical impact of HLA class I expression in rectal cancer
Frank M. Speetjens, Elza C. de Bruin, Hans Morreau, Eliane C. M. Zeestraten and Hein Putter, et al.
611-622
Original Article
An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2
Tsukasa Nabekura, Toshiro Nagasawa, Hiromitsu Nakauchi and Masafumi Onodera
623-634
Original Article
Adoptive transfer of Treg depleted autologous T cells in advanced renal cell carcinoma
Fiona C. Thistlethwaite, Eyad Elkord, Richard W. Griffiths, Deborah J. Burt and Alaaeldin M. Shablak, et al.
635-645
Original Article
Migration deficit in monocyte-macrophages in human ovarian cancer
Ralph S. Freedman, Qing Ma, Ena Wang, Stacie T. Gallardo and Ilyssa O. Gordon, et al.
647-654
Original Article
Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells
A. Nazmul H. Khan, Christopher J. Gregorie and Thomas B. Tomasi
655-662
Original Article
Ly49G2 receptor blockade reduces tumor burden in a leukemia model but not in a solid tumor model
Melissa A. Barber, Tong Zhang, Bethany A. Gagne, Jo A. Van Ginderachter and Patrick De Baetselier, et al.
663-675
Original Article
Augmentation of anti-tumor responses of adoptively transferred CD8+T cells in the lymphopenic setting by HSV amplicon transduction
Hovav Nechushtan, Dien Pham, Yu Zhang, Daniel Morgensztern and Kyung H. Yi, et al.
677-684
Original Article
Immunogenicity of Iodine 131 chimeric tumor necrosis therapy monoclonal antibody in advanced lung cancer patients
Hui Wang, Chuanping Cao, Beilei Li, Shaoliang Chen and Jun Yin, et al.
685-691
Original Article
Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy
Selma Ugurel, David Schrama, Gunhild Keller, Dirk Schadendorf and Eva-Bettina Bröcker, et al.
693-700
Original Article
MYCN as a target for cancer immunotherapy
Nourredine Himoudi, Mengyong Yan, Antigoni Papanastasiou and John Anderson
701-718
Original Article
Anti-inflammatory pretreatment enables an efficient dendritic cell-based immunotherapy against established tumors
Paula Chiarella, Marisa Vulcano, Juan Bruzzo, Mónica Vermeulen and Silvia Vanzulli, et al.
719-729
Original Article
Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines
Rosa Méndez, Teresa Rodríguez, Ana Del Campo, Eva Monge and Isabel Maleno, et al.
731-743
Original Article
Soluble factors released by activated cytotoxic T lymphocytes interfere with death receptor pathways in neuroblastoma
Anna De Geer, Lena-Maria Carlson, Per Kogner and Jelena Levitskaya
745-752
Original Article
A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytes
Pierre Larrieu, Virginie Renaud, Yann Godet, Francine Jotereau and Jean-François Fonteneau
753-757
Acknowledgement to Reviewers
Open AccessAcknowledgement